Portfolio company
Altoida
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops an augmented reality platform to assess cognitive function and detect Alzheimer's disease for healthcare providers and clinical researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Neurotrack
Neurotrack develops digital cognitive assessment tools and health programmes for healthcare providers and pharmaceutical companies to detect and manage Alzheimer's disease.
Mindmore
This company provides a digital platform for automated cognitive testing to healthcare clinics and patients with conditions affecting brain function.
Cognimark
This company develops AI software for healthcare providers to identify early signs of cognitive decline and dementia using existing electronic health records.
MindAhead
This company develops a digital therapy application for individuals with mild cognitive impairment and dementia to slow cognitive decline.
Novoic
This company develops speech-based artificial intelligence software to help clinicians and researchers detect early-stage neurological diseases, including Alzheimer's and Parkinson's.
Nuuron
This neurotech company develops a digital neuromodulation therapy delivered through virtual reality headsets to treat patients with Alzheimer's disease.
Optina Dx
The company develops an artificial intelligence platform and retinal imaging camera for the non-invasive detection of Alzheimer's disease and other systemic conditions for healthcare providers.
Cognito Tx
This company develops non-invasive wearable devices using light and sound stimulation to treat patients with Alzheimer's and other neurodegenerative diseases.
